Nula Therapeutics
PrivateLast Round
Seed
Apr 16, 2026
Total Funding Raised
$30M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nula Therapeutics is a biotechnology company that develops small-molecule drug candidates targeting the nuclear envelope to treat metabolic dysfunction and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nula Therapeutics Comparables
Compare Nula Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inipharm | 77% | |
| Roche Holding | 75% | |
| Galilei Biosciences | 70% | |
Nula Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 16, 2026 | ||||
| Grant | Feb 24, 2026 |
Nula Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Raised $10M in Seed funding.
- Feb 24, 2026
$20M grant received from ARPA-H.
Nula Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nula Therapeutics's valuation, stock price, and market status.